Jazz Pharmaceuticals (JAZZ) Q2 2026 Earnings

5MayConfirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-8.25
-2.79
2.67
8.13

Details

Expected EPS
4.641308
Actual EPS
6.34
Surprise EPS
1.7
Surprise Percent
+36.6%

Description

Jazz Pharmaceuticals (JAZZ) has reported earnings of 6.34 per share for Q2 2026.

0 Comments

Share your thoughts